Summary
Check out our latest interview with SOPHiA GENETICS, a company revolutionizing healthcare by leveraging data-driven technology to improve the diagnosis and treatment of cancer and rare diseases. In this conversation with Paul Chilo, Director of Governance, Risk & Compliance, we explore UNITY, a global oncology platform, and discuss the compliance strategy behind this international initiative, as well as our collaboration in making it a reality.
Here is the latest interview with one of our clients - SOPHiA GENETICS,. SOPHiA GENETICS was founded in 2011 by biologists who saw an opportunity to address the growing need for answers to diseases of the DNA.
They believed technology could make a positive and lasting impact on the world, using data for good.Their vision was to build a future in which each patient has equal access to world-class care, and today, they are well underway to realizing that impact. SOPHia has built a technology platform that distills complex data into actionable insights to reshape the way that cancer and rare inherited disorders are diagnosed and treated.
In this interview with Paul Chilo, Director of Governance, Risk & Compliance at SOPHiA GENETICS, we explore the latest initiative, UNITY, a global oncology platform. We discuss SOPHiA GENETICS’ compliance strategy for this international project, as well as our collaboration and partnership in bringing it to life.
FAQs
Our frequently questions
Find out how iliomad can help your company.
Only visible in production
EDPB Anonymisation Guidelines 2026 and Clinical Trial Data: What Life Sciences Organisations Must Know
EDPB Guidelines 02/2026 on anonymisation set new standards for clinical trial data. Learn the three-criteria test, enforcement lessons and compliance steps. iliomad.
AI Triage, Biopharma Workbenches and Crumbling Data Bridges: iliomad Weekly Digest
NHS AI triage, Anthropic Claude Science, medical AI privacy risks, MHRA GxP guidance, EDPS ADM checklist and the EU-US data transfer threat explained.
Human Intervention in Automated Decision-Making: What the EDPS Checklist Means for Life Sciences
The EDPS checklist on human intervention in automated decision-making carries direct implications for GDPR clinical trials. Learn what effective oversight requires.
